2025
Secondary hemochromatosis in a patient with supraventricular tachycardia and new decompensated heart failure
Baig M, Tysarowski M, Ruiz D, Fuss C, Baldassarre L. Secondary hemochromatosis in a patient with supraventricular tachycardia and new decompensated heart failure. Journal Of Cardiovascular Magnetic Resonance 2025, 27: 101736. DOI: 10.1016/j.jocmr.2024.101736.Peer-Reviewed Original Research
2024
Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia
Sullivan J, Pompa A, Schieber J, Arora G, Dionne A, Beach C. Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia. Journal Of Cardiovascular Electrophysiology 2024, 35: 2237-2241. PMID: 39313851, DOI: 10.1111/jce.16432.Peer-Reviewed Original ResearchCalcium channel blockersBeta blockersSupraventricular tachycardiaPediatric supraventricular tachycardiaChannel blockersAssociated with more side effectsCalcium-channel blockers patientsHemodynamically significant heart diseaseSide effectsMulticenter retrospective cohort studyEctopic atrial tachycardiaSignificant heart diseaseIntolerable side effectsRetrospective cohort studySuccess rateSupraventricular tachycardia diagnosisData abstraction toolAcademic children's hospitalIndividuals aged 1Pediatric arrhythmiasBB patientsDosage adjustmentAtrial tachycardiaTreatment successCohort studyCardiovascular and Cerebrovascular Adverse Events Associated with Intravitreal Anti-VEGF Monoclonal Antibodies A World Health Organization Pharmacovigilance Study
Yang J, Jung S, Kim M, Lee S, Yon D, Shin J, Lee J. Cardiovascular and Cerebrovascular Adverse Events Associated with Intravitreal Anti-VEGF Monoclonal Antibodies A World Health Organization Pharmacovigilance Study. Ophthalmology 2024, 132: 62-78. PMID: 39004231, DOI: 10.1016/j.ophtha.2024.07.008.Peer-Reviewed Original ResearchMeSH KeywordsAdverse Drug Reaction Reporting SystemsAgedAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabCardiovascular DiseasesCerebrovascular DisordersDatabases, FactualFemaleHumansIntravitreal InjectionsMaleMiddle AgedOdds RatioPharmacovigilanceRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsVascular Endothelial Growth Factor AWorld Health OrganizationConceptsIntravitreal anti-VEGF treatmentAdverse drug reactionsAnti-VEGF treatmentAnti-VEGFAtrial fibrillationIntravitreal anti-VEGF therapyCerebral hemorrhageIndividual case safety reportsInter-drugReports of myocardial infarctionMyocardial infarctionDisproportionate Bayesian reportingIntravitreal anti-VEGFAnti-VEGF therapyCarotid artery stenosisIncreasing reportsHypertensive crisisCase-noncase studySupraventricular tachycardiaAtrial flutterSubarachnoid hemorrhageIntravitrealArtery stenosisAngina pectorisOdds ratioReduced kinase function in two ultra‐rare TNNI3K variants in families with congenital junctional ectopic tachycardia
Pham C, Koopmann T, Vinocur J, Blom N, Silbiger V, Mittal K, Bootsma M, Palm K, Clur S, Barge‐Schaapveld D, Hamilton R, Lodder E. Reduced kinase function in two ultra‐rare TNNI3K variants in families with congenital junctional ectopic tachycardia. Clinical Genetics 2024, 106: 37-46. PMID: 38424693, DOI: 10.1111/cge.14504.Peer-Reviewed Original ResearchCongenital junctional ectopic tachycardiaJunctional ectopic tachycardiaK variantEctopic tachycardiaDilated CardiomyopathySupraventricular tachycardiaReduction of kinase activityAssociated with dilated cardiomyopathyFour-generation familyAtrioventricular (AV) nodeInteracting kinasesMissense variantsKinase functionTroponin I-interacting kinaseKinase activityTNNI3KGenetic penetranceTNNI3Variant carriersMultigenerational familiesGenetic testingTroponin ICardiac arrhythmiasTachycardiaVariants
2023
Outcomes in patients with COVID-19 and new onset heart blocks: Insight from the National Inpatient Sample database
Shoura S, Teaima T, Sana M, Abbasi A, Atluri R, Yilmaz M, Hammo H, Ali L, Kanitsoraphan C, Park D, Alyousef T. Outcomes in patients with COVID-19 and new onset heart blocks: Insight from the National Inpatient Sample database. World Journal Of Cardiology 2023, 15: 448-461. PMID: 37900263, PMCID: PMC10600784, DOI: 10.4330/wjc.v15.i9.448.Peer-Reviewed Original ResearchHigh-degree atrioventricular blockLength of hospital stayAcute kidney injuryBundle branch blockCOVID-19 pneumoniaTotal hospital chargesKidney injuryCardiogenic shockSupraventricular tachycardiaMechanical ventilationVentricular tachycardiaCardiac arrestBundle branch block groupInpatient mortalityNational Inpatient Sample (NIS) databaseOdds of in-hospital mortalitySARS-CoV-2Left bundle branch blockNational Inpatient Sample databasePre-existing pacemakersStata version 17In-Hospital MortalityCardiac conduction systemInpatient Sample databaseOdds of inpatient mortalityRates and predictors of hospital and emergency department care after catheter ablation of atrial fibrillation
Friedman D, Freeman J, Wong C, Febre J, Iglesias M, Khanna R, Piccini J. Rates and predictors of hospital and emergency department care after catheter ablation of atrial fibrillation. Journal Of Cardiovascular Electrophysiology 2023, 34: 823-830. PMID: 36738152, DOI: 10.1111/jce.15841.Peer-Reviewed Original ResearchConceptsPredictors of hospitalED careAF ablationED visitsPatient comorbiditiesSupraventricular tachycardiaUnscheduled careFemale sexCommon reasonDirect oral anticoagulationEmergency department evaluationNoncardiac chest painDays of dischargeRisk of rehospitalizationAtrial fibrillation ablationEmergency department careSame-day discharge programQuality improvement initiativesOptum Clinformatics databaseAdmission careMean CHAOral anticoagulationPostablation periodVASc scoreChest pain
2022
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises
Miyake CY, Lay EJ, Beach CM, Ceresnak SR, Delauz CM, Howard TS, Janson CM, Jardine K, Kannankeril PJ, Kava M, Kim JJ, Liberman L, Macicek SL, Pham TD, Robertson T, Valdes SO, Webster G, Stephens SB, Milewicz DM, Azamian M, Ehsan SA, Houck KM, Soler-Alfonso C, Glinton KE, Tosur M, Li N, Xu W, Lalani SR, Zhang L. Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises. Heart Rhythm 2022, 19: 1673-1681. PMID: 35568137, PMCID: PMC10642301, DOI: 10.1016/j.hrthm.2022.05.009.Peer-Reviewed Original ResearchConceptsVentricular tachycardiaCardiac crisisCardiac arrestMetabolic crisisIntravenous magnesiumAtrial pacingCardiac arrhythmiasRetrospective multicenter chart reviewType I Brugada patternInitiation of feedsMulticenter chart reviewMembrane oxygenation supportCurrent treatment optionsAutosomal recessive diseaseLethal cardiac arrhythmiasBrugada patternOxygenation supportCardiac manifestationsChart reviewQTc prolongationAntiarrhythmic drugsHeart blockSupraventricular tachycardiaTreatment optionsSuccessful treatmentApproach to Wide Complex Tachycardia in Paediatric Patients
Escudero C, Tan R, Beach C, Dalal A, LaPage M, Hill A. Approach to Wide Complex Tachycardia in Paediatric Patients. CJC Pediatric And Congenital Heart Disease 2022, 1: 60-73. PMID: 37969244, PMCID: PMC10642107, DOI: 10.1016/j.cjcpc.2022.02.003.Peer-Reviewed Original ResearchWide complex tachycardiaPediatric patientsComplex tachycardiaVariety of causesYounger patientsChronic managementUnstable patientsTreatment optionsSupraventricular tachycardiaVentricular pacingAccessory pathwayVentricular tachycardiaDifferential diagnosisDiagnostic maneuversTachycardia terminationPatientsTachycardiaVentricular activationElectrocardiographic tracingsAberrant conductionUnderlying causeCareful reviewPotential causesCauseReview
2021
Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database
Kim M, Jung Y, Ahn J, Park J, Shoenfeld Y, Kronbichler A, Koyanagi A, Dragioti E, Tizaoui K, Hong S, Jacob L, Salem J, Yon D, Lee S, Ogino S, Kim H, Kim J, Excler J, Marks F, Clemens J, Eisenhut M, Barnett Y, Butler L, Ilie C, Shin E, Shin J, Smith L. Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database. Journal Of Medical Virology 2021, 94: 1085-1095. PMID: 34709664, PMCID: PMC8662238, DOI: 10.1002/jmv.27424.Peer-Reviewed Original ResearchConceptsMessenger RNA vaccineMessenger RNA COVID-19 vaccineCOVID-19 mRNA vaccinesInfluenza vaccineSafety profileAdverse eventsMRNA vaccinesMessenger RNARisk of neurological complicationsCOVID-19 vaccineGuillain-Barre syndromeComparative safety studyReactogenicity eventsSafety of mRNA vaccinesHypertensive crisisLoss of consciousnessNeurological complicationsSupraventricular tachycardiaCardiovascular complicationsSafety signalsInfluenzaPfizer-BioNTech
2016
The Association between Nocturnal Cardiac Arrhythmias and Sleep-Disordered Breathing: The DREAM Study.
Selim BJ, Koo BB, Qin L, Jeon S, Won C, Redeker NS, Lampert RJ, Concato JP, Bravata DM, Ferguson J, Strohl K, Bennett A, Zinchuk A, Yaggi HK. The Association between Nocturnal Cardiac Arrhythmias and Sleep-Disordered Breathing: The DREAM Study. Journal Of Clinical Sleep Medicine 2016, 12: 829-37. PMID: 26951420, PMCID: PMC4877315, DOI: 10.5664/jcsm.5880.Peer-Reviewed Original ResearchConceptsSleep-disordered breathingNocturnal cardiac arrhythmiasIntraventricular conduction delayApnea-hypopnea indexCardiac arrhythmiasTwo-fold oddsModerate-severe sleep-disordered breathingSeverity of SDBSevere sleep-disordered breathingComplex ventricular ectopyMultiple cardiovascular comorbiditiesObstructive respiratory eventsClinic-based populationCross-sectional analysisCardiovascular comorbiditiesSDB patientsVentricular ectopySDB severityRespiratory eventsUnadjusted oddsSupraventricular tachycardiaCardiovascular diseaseArrhythmia subtypesArrhythmia riskConduction delay
2015
A Smartphone Application to Diagnose the Mechanism of Pediatric Supraventricular Tachycardia
Ferdman DJ, Liberman L, Silver ES. A Smartphone Application to Diagnose the Mechanism of Pediatric Supraventricular Tachycardia. Pediatric Cardiology 2015, 36: 1452-1457. PMID: 25958154, DOI: 10.1007/s00246-015-1185-6.Peer-Reviewed Original ResearchConceptsAtrioventricular nodal reentrant tachycardiaAtrioventricular reentrant tachycardiaSupraventricular tachycardiaPediatric patientsReentrant tachycardiaHolter monitorNodal reentrant tachycardiaPediatric supraventricular tachycardiaChi-square testSingle-lead ECGPediatric electrophysiologistsProspective studyRetrograde P wavesSVT mechanismTachycardia mechanismCorrect diagnosisPatientsPairs of sinusesTachycardiaSmartphone applicationECG
1994
Management outcome and follow-up of fetal tachycardia
van Engelen A, Weijtens O, Brenner J, Kleinman C, Copel J, Stoutenbeek P, Meijboom E. Management outcome and follow-up of fetal tachycardia. Journal Of The American College Of Cardiology 1994, 24: 1371-1375. PMID: 7930263, DOI: 10.1016/0735-1097(94)90122-8.Peer-Reviewed Original ResearchConceptsFetal tachycardiaMajority of patientsPharmacologic therapyFetal hydropsAtrial flutterSupraventricular tachycardiaVentricular tachycardiaPresence of hydropsSeries of patientsLife-threatening conditionSerious adverse effectsMonths of ageMaternal therapyProlonged therapyPostpartum managementRhythm controlAntiarrhythmic agentsMedian numberDrug treatmentTachycardiaM-modePatientsOptimal managementTherapyEmergency delivery
1990
Two Accessory Pathways, Dual AV Nodal Conduction, and 1:2 Ventriculoatrial Conduction in a Patient with Multiple Supraventricular Tachycardias
ROSENFELD L, BATSFORD W. Two Accessory Pathways, Dual AV Nodal Conduction, and 1:2 Ventriculoatrial Conduction in a Patient with Multiple Supraventricular Tachycardias. Pacing And Clinical Electrophysiology 1990, 13: 171-178. PMID: 1689833, DOI: 10.1111/j.1540-8159.1990.tb05067.x.Peer-Reviewed Original Research
1985
Treatment of fetal supraventricular tachyarrhythmias
Kleinman C, Copel J, Weinstein E, Santulli T, Hobbins J. Treatment of fetal supraventricular tachyarrhythmias. Journal Of Clinical Ultrasound 1985, 13: 265-273. PMID: 3923049, DOI: 10.1002/jcu.1870130406.Peer-Reviewed Original ResearchConceptsNormal sinus rhythmSupraventricular tachyarrhythmiasSinus rhythmAtrial flutterFetal supraventricular tachyarrhythmiaTime of diagnosisYale-New Haven Medical CenterSevere fetal hydropsAntiarrhythmic therapyElectrical cardioversionMaternal administrationDoppler echocardiographyAtrial fibrillationFetal hydropsAntiarrhythmic agentsElectrophysiologic mechanismsSupraventricular tachycardiaMedical CenterSuccessful therapyCardiac rhythmM-modeFetusesTreatment programTachyarrhythmiasFibrillation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply